Bestimmung von Antikörpern gegen Cytomegalievirus (CMV), Varizella/Zoster-Virus (VZV) und Herpes simplex-Virus Typ 1 (HSV-1) im Enzyme-Linked-Immunosorbent-Assay (ELISA)

1978 ◽  
Vol 290 (2) ◽  
pp. 100-101 ◽  
Author(s):  
R. Ziegelmaier ◽  
H. Schneider ◽  
J. Hilfenhaus ◽  
H. Thierfelder ◽  
F. Behrens ◽  
...  
1987 ◽  
Vol 17 (1-2) ◽  
pp. 159-174 ◽  
Author(s):  
J.M. Middeldorp ◽  
A.M. Hooymans ◽  
A.J.H.F. Kocken ◽  
A.M. van Loon ◽  
J.A. Emsbroek ◽  
...  

1999 ◽  
Vol 37 (2) ◽  
pp. 376-379 ◽  
Author(s):  
D. Scott Schmid ◽  
Denise R. Brown ◽  
Rosane Nisenbaum ◽  
Rae Lyn Burke ◽  
D’Anna Alexander ◽  
...  

Type-specific serologic assays for herpes simplex virus (HSV) types 1 and 2 based on glycoprotein G-1 (gG-1) (HSV-1) and gG-2 (HSV-2) discriminate between antibodies against HSV-1 and HSV-2. We previously developed a Western blot assay using gG-1 and gG-2 expressed in baculovirus, performed extensive validation studies, and determined that it was both sensitive and specific for type-specific detection of HSV antibody. Here we report that, among a cohort of Thai military recruits, the serostatus of some individuals changed from positive to negative over time (6.6% among those ever positive for HSV-1, and 14.9% among those ever positive for HSV-2). We tested a subset of these specimens in three other gG-based assays: an enzyme-linked immunosorbent assay, an immunoblot strip assay, and a Western blot assay. Positive-to-negative shifts occurred in every assay; the frequency of the shifts ranged from 6.1% to 21.2% of the specimen sets tested. There was only limited agreement among the assays concerning which individuals lost reactivity. This inaccuracy, exhibited by all of the assay protocols, was not predicted by validation studies employing specimens from cross-sectional studies and was most pronounced in HSV-2 testing. This argues for the inclusion of serial blood specimens in serologic assay validation procedures.


2021 ◽  
Vol 66 (5) ◽  
pp. 285-290
Author(s):  
N. N. Shershneva ◽  
S. S. Mardanly ◽  
I. N. Klenyaev ◽  
P. V. Samosadova

The Russian kits «HSV-1-Fluorogen-screen» and «HSV-2-Fluorogen-screen» have been developed for the determination of antibodies M and G to herpes simplex virus types 1 and 2 by the immunofluorescence reaction. The kits were used to examine the positive and negative standard «EKOlab» panels sera and showed 100% sensitivity and specificity of the developed tests. 125 samples of blood serum from people with clinical diagnoses such as herpetic, cytomegalovirus infections, pyelonephritis, conjunctivitis and central nervous system damage were tested in parallel with using the enzyme-linked immunosorbent assay systems from different manufacturers and the developed tests «HSV-1-Fluorogen-screen» and «HSV-2-Fluorogen-screen». A high degree of matching of results with comparison sets was observed in examined samples. The developed diagnostics can be successfully used in clinical practice both for screening and for verification of results of the diagnosis of herpesvirus infections caused by herpes simplex virus types 1 and 2.


Sign in / Sign up

Export Citation Format

Share Document